vs

Side-by-side financial comparison of VIEMED HEALTHCARE, INC. (VMD) and WisdomTree, Inc. (WT). Click either name above to swap in a different company.

WisdomTree, Inc. is the larger business by last-quarter revenue ($147.4M vs $76.2M, roughly 1.9× VIEMED HEALTHCARE, INC.). WisdomTree, Inc. runs the higher net margin — 27.1% vs 7.4%, a 19.7% gap on every dollar of revenue. On growth, WisdomTree, Inc. posted the faster year-over-year revenue change (33.2% vs 25.5%). WisdomTree, Inc. produced more free cash flow last quarter ($147.7M vs $9.7M). Over the past eight quarters, WisdomTree, Inc.'s revenue compounded faster (23.4% CAGR vs 22.7%).

Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.

WisdomTree, Inc. is a global exchange-traded fund (ETF) and exchange-traded product (ETP) sponsor and asset manager with headquarters in New York. WisdomTree launched its first ETFs in June 2006, and became one of the major ETF providers in the United States. WisdomTree sponsors different ETFs that span asset classes and countries worldwide. Categories include: U.S. and International Equity, Currency, Fixed Income and Alternatives.

VMD vs WT — Head-to-Head

Bigger by revenue
WT
WT
1.9× larger
WT
$147.4M
$76.2M
VMD
Growing faster (revenue YoY)
WT
WT
+7.7% gap
WT
33.2%
25.5%
VMD
Higher net margin
WT
WT
19.7% more per $
WT
27.1%
7.4%
VMD
More free cash flow
WT
WT
$138.0M more FCF
WT
$147.7M
$9.7M
VMD
Faster 2-yr revenue CAGR
WT
WT
Annualised
WT
23.4%
22.7%
VMD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
VMD
VMD
WT
WT
Revenue
$76.2M
$147.4M
Net Profit
$5.6M
$40.0M
Gross Margin
57.9%
Operating Margin
11.0%
40.5%
Net Margin
7.4%
27.1%
Revenue YoY
25.5%
33.2%
Net Profit YoY
30.7%
46.6%
EPS (diluted)
$0.14
$0.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
VMD
VMD
WT
WT
Q4 25
$76.2M
$147.4M
Q3 25
$71.9M
$125.6M
Q2 25
$63.1M
$112.6M
Q1 25
$59.1M
$108.1M
Q4 24
$60.7M
$110.7M
Q3 24
$58.0M
$113.2M
Q2 24
$55.0M
$107.0M
Q1 24
$50.6M
$96.8M
Net Profit
VMD
VMD
WT
WT
Q4 25
$5.6M
$40.0M
Q3 25
$3.5M
$19.7M
Q2 25
$3.2M
$24.8M
Q1 25
$2.6M
$24.6M
Q4 24
$4.3M
$27.3M
Q3 24
$3.9M
$-4.5M
Q2 24
$1.5M
$21.8M
Q1 24
$1.6M
$22.1M
Gross Margin
VMD
VMD
WT
WT
Q4 25
57.9%
Q3 25
57.5%
Q2 25
58.3%
Q1 25
56.3%
Q4 24
59.5%
Q3 24
59.3%
Q2 24
59.8%
Q1 24
58.9%
Operating Margin
VMD
VMD
WT
WT
Q4 25
11.0%
40.5%
Q3 25
7.8%
36.3%
Q2 25
8.1%
30.8%
Q1 25
6.5%
31.6%
Q4 24
10.6%
31.7%
Q3 24
9.7%
36.0%
Q2 24
6.6%
31.3%
Q1 24
4.4%
28.9%
Net Margin
VMD
VMD
WT
WT
Q4 25
7.4%
27.1%
Q3 25
4.9%
15.7%
Q2 25
5.0%
22.0%
Q1 25
4.4%
22.8%
Q4 24
7.1%
24.7%
Q3 24
6.7%
-4.0%
Q2 24
2.7%
20.3%
Q1 24
3.2%
22.8%
EPS (diluted)
VMD
VMD
WT
WT
Q4 25
$0.14
$0.28
Q3 25
$0.09
$0.13
Q2 25
$0.08
$0.17
Q1 25
$0.06
$0.17
Q4 24
$0.10
$0.20
Q3 24
$0.10
$-0.13
Q2 24
$0.04
$0.13
Q1 24
$0.04
$0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
VMD
VMD
WT
WT
Cash + ST InvestmentsLiquidity on hand
$13.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$141.5M
$413.7M
Total Assets
$199.2M
$1.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
VMD
VMD
WT
WT
Q4 25
$13.5M
Q3 25
$11.1M
Q2 25
$20.0M
Q1 25
$10.2M
Q4 24
$17.5M
Q3 24
$11.3M
Q2 24
$8.8M
$132.5M
Q1 24
$7.3M
$116.9M
Stockholders' Equity
VMD
VMD
WT
WT
Q4 25
$141.5M
$413.7M
Q3 25
$133.6M
$373.4M
Q2 25
$139.7M
$445.1M
Q1 25
$134.8M
$415.6M
Q4 24
$131.4M
$400.0M
Q3 24
$125.0M
$374.9M
Q2 24
$119.4M
$445.6M
Q1 24
$116.3M
$423.2M
Total Assets
VMD
VMD
WT
WT
Q4 25
$199.2M
$1.5B
Q3 25
$202.4M
$1.4B
Q2 25
$184.6M
$1.1B
Q1 25
$178.1M
$1.0B
Q4 24
$177.1M
$1.0B
Q3 24
$169.5M
$1.0B
Q2 24
$163.9M
$964.1M
Q1 24
$154.9M
$931.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
VMD
VMD
WT
WT
Operating Cash FlowLast quarter
$18.4M
$147.9M
Free Cash FlowOCF − Capex
$9.7M
$147.7M
FCF MarginFCF / Revenue
12.7%
100.2%
Capex IntensityCapex / Revenue
11.5%
0.1%
Cash ConversionOCF / Net Profit
3.27×
3.70×
TTM Free Cash FlowTrailing 4 quarters
$11.9M
$240.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
VMD
VMD
WT
WT
Q4 25
$18.4M
$147.9M
Q3 25
$18.4M
$48.1M
Q2 25
$12.3M
$38.8M
Q1 25
$2.9M
$6.4M
Q4 24
$15.0M
$113.5M
Q3 24
$12.7M
$47.7M
Q2 24
$10.2M
$32.2M
Q1 24
$1.2M
$-1.0M
Free Cash Flow
VMD
VMD
WT
WT
Q4 25
$9.7M
$147.7M
Q3 25
$10.7M
$48.0M
Q2 25
$4.1M
$38.7M
Q1 25
$-12.6M
$6.3M
Q4 24
$3.2M
$113.3M
Q3 24
$1.7M
$47.7M
Q2 24
$1.2M
$32.2M
Q1 24
$-4.8M
$-1.1M
FCF Margin
VMD
VMD
WT
WT
Q4 25
12.7%
100.2%
Q3 25
14.9%
38.2%
Q2 25
6.5%
34.4%
Q1 25
-21.4%
5.9%
Q4 24
5.2%
102.4%
Q3 24
3.0%
42.1%
Q2 24
2.3%
30.1%
Q1 24
-9.5%
-1.1%
Capex Intensity
VMD
VMD
WT
WT
Q4 25
11.5%
0.1%
Q3 25
10.6%
0.0%
Q2 25
12.9%
0.1%
Q1 25
26.2%
0.0%
Q4 24
19.5%
0.1%
Q3 24
19.0%
0.0%
Q2 24
16.3%
0.0%
Q1 24
11.9%
0.1%
Cash Conversion
VMD
VMD
WT
WT
Q4 25
3.27×
3.70×
Q3 25
5.23×
2.44×
Q2 25
3.88×
1.57×
Q1 25
1.09×
0.26×
Q4 24
3.47×
4.15×
Q3 24
3.29×
Q2 24
6.94×
1.48×
Q1 24
0.73×
-0.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

VMD
VMD

Segment breakdown not available.

WT
WT

Investment Advisory Management And Administrative Service$122.7M83%
Other Services Income$12.7M9%
IE$11.5M8%

Related Comparisons